Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
Review Open access

Dapagliflozin and empagliflozin versus placebo for cardiovascular death or worsening heart failure across the ejection-fraction spectrum: a systematic review and meta-analysis of randomized placebo-controlled trials

Nawaf AM Alharbi Abdullah Ahmed Alfllaj Mohamed Ghaith Al Abdin Lana Musaad Alhatlani I. Fathi Ibrahim Suliman Nawaf AM Alharbi Al Abdin Lana Musaad Alhatlani Ibrahim Suliman
Oct 2026 · International Journal of Drug Delivery Technology · 0 citations · 28 references

Abstract

Background and aims: Dapagliflozin and empagliflozin are established therapy for chronic heart failure across the ejection-fraction spectrum. Their pivotal trials were powered for a composite of cardiovascular death and worsening heart failure

DOI Semantic Scholar
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.